181 results match your criteria: "'A. Sygros' Hospital for Cutaneous & Venereal Diseases[Affiliation]"

Use of omalizumab is associated with improvement of pruritic skin disorders induced by immune checkpoint inhibitors: A retrospective cohort from the European Task Force of Dermatology for Cancer patients.

J Am Acad Dermatol

February 2024

Department of Dermatology, Hospital Clínic de Barcelona, FRCB, Universitat de Barcelona, Barcelona, Spain; Centro de Investigación Biomédica en Red (CIBER) de Enfermedades Raras, Instituto de Salud Carlos III, Madrid, Spain. Electronic address:

View Article and Find Full Text PDF
Article Synopsis
  • * Despite a good prognosis, cSCC leads to many deaths because of its high occurrence, highlighting the importance of ongoing research and treatment recommendations.
  • * A group of experts from various European dermatological and oncology organizations has come together to update guidelines on cSCC, focusing on various aspects such as classification, diagnosis, risk factors, and prevention for both immunocompetent and immunosuppressed individuals.
View Article and Find Full Text PDF

European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.

Eur J Cancer

November 2023

Division of Cancer Sciences, University of Manchester, Manchester, UK; Department of Medical Oncology, Christie NHS Foundation Trust, Manchester, UK.

Article Synopsis
  • A multidisciplinary panel of experts from various European medical organizations has developed updated recommendations for treating invasive cutaneous squamous cell carcinoma (cSCC) based on a thorough literature review and expert consensus.
  • Treatment guidelines cover different stages of cSCC, recommending surgery with clear margins as the primary option for low and high-risk cases, while highlighting the lack of benefit from radiation for high-risk patients with clear margins.
  • For advanced cSCC that cannot be surgically treated, anti-PD-1 agents like cemiplimab are recommended as first-line therapy, with second-line options including cetuximab combined with chemotherapy or radiation.
View Article and Find Full Text PDF

Background: Subungual melanoma (SUM) is a rare type of cutaneous malignant melanoma (CMM) associated with poor prognosis, while data regarding its prevalence are scarce.

Objectives: We sought to provide a comprehensive systematic review and meta-analysis of the prevalence rates of SUM among all types of CMM, considering certain demographic and clinical characteristics.

Methods: The MEDLINE electronic database was searched systematically to identify eligible studies providing prevalence rate estimates of SUM in patients with CMM.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the transition from actinic keratosis (AK) to cutaneous squamous cell carcinoma (cSCC), highlighting unclear mechanisms driving disease progression despite observed genetic mutations.
  • RNA sequencing of 110 patient samples shows a progression from differentiated skin cells to a progenitor-like state, involving the suppression of genes responsible for skin cell differentiation and alterations in immune response.
  • The research identifies a specific combination of tumor suppressor gene inactivation and Ras signaling activation that contributes to the development and progression of cSCC, providing insights for potential therapeutic interventions.
View Article and Find Full Text PDF
Article Synopsis
  • Basal cell carcinoma (BCC) is the most prevalent skin cancer in white populations, and updated guidelines for its diagnosis and treatment have been established by a collaboration of various European medical organizations.
  • BCCs are classified into 'easy-to-treat' and 'difficult-to-treat' types, with complete surgical removal as the primary treatment method; alternative treatments include topical therapies, radiotherapy, and immunotherapy for more advanced cases.
  • Regular skin examinations and long-term follow-ups are crucial for patients at higher risk for BCC, including those with Gorlin syndrome or multiple lesions.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates cutaneous adverse reactions in advanced breast cancer patients treated with cyclin-dependent kinase inhibitors (CDK4/6i), focusing on their types, severity, and treatment outcomes.
  • Researchers analyzed data from 79 patients across 11 countries, documenting 165 skin-related issues, with the most common being pruritus, alopecia, and eczematous lesions.
  • Most reactions were mild and managed with topical treatments, with only a small percentage leading to treatment discontinuation.
View Article and Find Full Text PDF

Background: Limited data on immune checkpoint inhibitor (ICI)-induced pruritus per se and efficacy of different therapeutic modalities in its management exist.

Objective: To study the quantitative and qualitative characteristics of ICI-induced pruritus per se and to assess the efficacy of the therapeutic modalities usually applied.

Methods: We retrospectively reviewed the records of 91 patients who were under treatment with ICIs for any kind of neoplasia and developed pruritus during treatment.

View Article and Find Full Text PDF

The Natural Evolution of Nevi with Peripheral Globules.

Dermatology

October 2023

First Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University, Thessaloniki, Greece.

Background: Peripheral globules (PG) in melanocytic lesions represent a concerning dermoscopic feature since they might be present in growing nevi and melanomas. Their natural evolution has not been fully elucidated, and an age-based management approach has been recommended.

Objectives: The aim of this study was to calculate the growth rate of lesions with PG and investigate possible association with age, sex, location, and the global dermoscopic pattern.

View Article and Find Full Text PDF

Eccrine Porocarcinoma: A Review of the Literature.

Diagnostics (Basel)

April 2023

1st Department of Dermatology-Venereology, Faculty of Medicine, National and Kapodistrian University of Athens, Andreas Sygros Hospital, 16121 Athens, Greece.

Eccrine porocarcinoma (EPC) constitutes a rare malignant adnexal tumor, which accounts for about 0.005-0.01% of all cutaneous malignancies.

View Article and Find Full Text PDF

Background: Hidradenitis suppurutiva (HS) is a chronic auto-inflammatory disease with recurrent painful deep-seated nodules.

Aims: The aim of this study was to qualitatively assess patients' perception for HS.

Methods: A descriptive two-step questionnaire survey was conducted from January 2017 to December 2018.

View Article and Find Full Text PDF

Dermoscopic Clues of Histopathologically Aggressive Basal Cell Carcinoma Subtypes.

Medicina (Kaunas)

February 2023

First Dermatology Department, School of Medicine, Faculty of Health Sciences, Aristotle University of Thessaloniki, 54643 Thessaloniki, Greece.

The group of histopathologically aggressive BCC subtypes includes morpheaform, micronodular, infiltrative and metatypical BCC. Since these tumors are at increased risk of recurring, micrographically controlled surgery is considered the best therapeutic option. Although dermoscopy significantly improves the clinical recognition of BCC, scarce evidence exists on their dermoscopic criteria.

View Article and Find Full Text PDF

: Cutaneous melanoma has an adjacent nevus remnant upon histological examination in 30% of cases (nevus-associated melanoma, NAM), while it appears for 70% of tumors. Regarding NAM arising in acquired melanocytic nevus, currently there is no evidence on whether NAM more frequently develops in association with a dysplastic or common melanocytic nevus. : To conduct a systematic review and meta-analysis to investigate the proportion of dysplastic or common melanocytic nevus in NAM associated with acquired nevus.

View Article and Find Full Text PDF
Article Synopsis
  • * Data from 101 cases across 13 countries showed that skin lesions were often the first symptoms of infection, evolving from papules and vesicles to pustules and crusts/scabs as the infection progressed.
  • * The research indicates notable differences from past outbreaks, including early skin lesions and a risk of scarring, while acknowledging potential biases in the registry data.
View Article and Find Full Text PDF

An Epidemiological Update on Indoor Tanning and the Risk of Skin Cancers.

Curr Oncol

November 2022

Melanoma and Skin Cancer Unit, 1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, 16121 Athens, Greece.

Indoor tanning (sunbeds, solarium) uses artificial ultraviolet radiation (UVR) to stimulate cosmetic tanning of the skin. Indoor tanning has been officially classified as a human carcinogen in 2009 by the International Agency for Research on Cancer of the World Health Organization (WHO). The differences in the prevalence of sunbed use across countries and over the years highlight underlying legislative, climatic, and cultural differences.

View Article and Find Full Text PDF

The American Academy of Dermatology and International League of Dermatological Societies Monkeypox Registry: Expanding the COVID-19 registry to emerging infections.

J Am Acad Dermatol

December 2022

Department of Dermatology, University Hospital, Munich University of Ludwig Maximilian, Munich, Germany; Dr. Philip Frost, Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida.

The World Health Organization declared the global monkeypox outbreak a public health emergency of international concern in July 2022. In response, the American Academy of Dermatology and International League of Dermatological Societies expanded the existing COVID-19 Dermatology Registry to become the "AAD/ILDS Dermatology COVID-19, Monkeypox, and Emerging Infections Registry." The goal of the registry is to rapidly collate cases of monkeypox and other emerging infections and enable prompt dissemination of findings to front-line healthcare workers and other members of the medical community.

View Article and Find Full Text PDF

Recent Advances in the Diagnosis and Management of High-Risk Cutaneous Squamous Cell Carcinoma.

Cancers (Basel)

July 2022

1st Department of Dermatology, Skin Cancer and Melanoma Unit, Andreas Sygros Hospital, University of Athens, 16121 Athens, Greece.

High-risk cSCC is defined as invasive cSCC staged as N0 (without detectable regional lymph nodes) and M0 (without distant metastasis), that has features associated with a higher risk of poorer prognosis. The focus of this review is on the recent advances in the diagnosis and management of high-risk cSCC. The interest in high-risk cSCC relies on its higher risk of progression to advanced cSCC, as it represents the main pool of cSCCs that give rise to advanced tumors.

View Article and Find Full Text PDF
Article Synopsis
  • Cutaneous immune-related adverse events (irAEs) are the most common side effects experienced by cancer patients undergoing treatment with immune checkpoint inhibitors (ICIs), with a wide variety of skin toxicities identified.
  • A study of 762 patients revealed 993 instances of cutaneous toxicities, with psoriasis and pruritus being the most prevalent reactions.
  • The findings indicate that the type of ICI therapy and the underlying cancer can significantly influence the occurrence and type of skin toxicities, highlighting the need for tailored follow-up plans for affected patients.
View Article and Find Full Text PDF

A review of nevus-associated melanoma: What is the evidence?

J Eur Acad Dermatol Venereol

November 2022

1st Department of Dermatology-Venereology, National and Kapodistrian University of Athens, Andreas Sygros Hospital, Athens, Greece.

Cutaneous melanoma may have an adjacent nevus remnant on histological examination in 30% of cases (nevus-associated melanoma, NAM), while it may appear de novo, without a precursor lesion, in the remaining 70% of cases. Nevus-associated melanoma and the concept of acquired melanocytic nevi serving as precursors of melanoma has long been considered as a controversial topic. This controversy is, in part, due to their overall low rate of transformation to melanoma and scarce data on the natural history of progression.

View Article and Find Full Text PDF

Atopic Dermatitis: Sailing beyond the Sunset with a Multitude of Novel Treatments.

J Clin Med

June 2022

Department of Dermatology, Venereology and Allergology, Wroclaw Medical University, 50-367 Wroclaw, Poland.

Atopic eczema or dermatitis (AD) is a chronic pruritic inflammatory cutaneous disorder with an incidence up to 20% in children and 10% in adults depending on region and ethnicity [...

View Article and Find Full Text PDF